HCT 3012 - COX-Inhibiting Nitric Oxide-Donator (CINOD) for Relief of Pain and Inflammation

 
Key Data:
Drug (brand / generic)
HCT 3012
Company/Licensee
NicOx SA
Therapy Class
CINOD
Product Description
COX-inhibiting nitric oxide donator
Current Indication
Treatment of acute and chronic nociceptive pain
Market Sector
Pain (analgesics/antiinflammtories)
Development Status
Phase III



Home
New On This Site
Products & Services
Company A-Z
Industry Projects
White Papers
Jobs & Careers
Press Releases
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area

For every phase of your drug development